PT1389122E - Prevenção do cancro epitelial - Google Patents

Prevenção do cancro epitelial Download PDF

Info

Publication number
PT1389122E
PT1389122E PT02759763T PT02759763T PT1389122E PT 1389122 E PT1389122 E PT 1389122E PT 02759763 T PT02759763 T PT 02759763T PT 02759763 T PT02759763 T PT 02759763T PT 1389122 E PT1389122 E PT 1389122E
Authority
PT
Portugal
Prior art keywords
cancer
epithelial cancer
prostate
bladder
lung
Prior art date
Application number
PT02759763T
Other languages
English (en)
Inventor
Hans Henrik Raskov
Original Assignee
Hans Henrik Raskov
Colotech As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/825,891 external-priority patent/US6703380B2/en
Application filed by Hans Henrik Raskov, Colotech As filed Critical Hans Henrik Raskov
Publication of PT1389122E publication Critical patent/PT1389122E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
PT02759763T 2001-04-05 2002-04-05 Prevenção do cancro epitelial PT1389122E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/825,891 US6703380B2 (en) 1999-09-29 2001-04-05 Prevention of cancer

Publications (1)

Publication Number Publication Date
PT1389122E true PT1389122E (pt) 2009-12-23

Family

ID=25245159

Family Applications (1)

Application Number Title Priority Date Filing Date
PT02759763T PT1389122E (pt) 2001-04-05 2002-04-05 Prevenção do cancro epitelial

Country Status (12)

Country Link
EP (1) EP1389122B1 (pt)
AT (1) ATE444072T1 (pt)
AU (1) AU2002338311B2 (pt)
CA (1) CA2445940C (pt)
DE (1) DE60233869D1 (pt)
DK (1) DK1389122T3 (pt)
ES (1) ES2334215T3 (pt)
IS (1) IS6976A (pt)
NO (1) NO20034381L (pt)
NZ (1) NZ529104A (pt)
PT (1) PT1389122E (pt)
WO (1) WO2002080889A2 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20135701L (fi) * 2013-06-26 2014-12-27 Mas Metabolic Analytical Services Oy Farmaseuttisesti käyttökelpoinen ja turvallinen kombinaatio käytettäväksi merkittävien sairauksien hoidossa

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5948443A (en) * 1996-02-23 1999-09-07 Medical Doctor's Research Institute, Inc. Acetylsalicylic acid and micronutrient supplementation for nutritional losses and coronary heart disease
PT1220676E (pt) * 1999-09-29 2005-08-31 Coloctech As Prevencao do cancro colorrectal

Also Published As

Publication number Publication date
ATE444072T1 (de) 2009-10-15
WO2002080889A2 (en) 2002-10-17
EP1389122B1 (en) 2009-09-30
EP1389122A2 (en) 2004-02-18
WO2002080889A3 (en) 2003-02-20
NZ529104A (en) 2004-05-28
NO20034381D0 (no) 2003-10-01
CA2445940A1 (en) 2002-10-17
CA2445940C (en) 2010-08-24
AU2002338311B2 (en) 2006-08-10
ES2334215T3 (es) 2010-03-08
NO20034381L (no) 2003-12-05
DK1389122T3 (da) 2010-02-01
IS6976A (is) 2003-10-03
DE60233869D1 (de) 2009-11-12

Similar Documents

Publication Publication Date Title
MXPA05011208A (es) Uso de ivermectina para el tratamiento de desordenes dermatologicos.
MY127290A (en) New use of flibanserin
WO2007062093A3 (en) Combination therapy for the treatment of cancer comprising a metalloprotease inhibitor
MX347237B (es) Formulaciones farmaceuticas y usos de las mismas en el tratamiento de la disfuncion sexual femenina.
WO2005082413A3 (en) Ciclesonide and glycopyrronium combination
BRPI0508333A (pt) uso de um composto de vitamina d, método de prevenir e/ou tratar cistite intersticial, formulação farmacêutica, composto de vitamina d, e, kit
PT1220676E (pt) Prevencao do cancro colorrectal
AU7862401A (en) Pharmaceutical compostion comprising trkaig2 for use in the prevention and/or treatment of cancer
WO2005105135A8 (en) Il-6 for therapy or prevention of chemotherapy-induced neuropathy
PT1670489E (pt) Utilização de xénon com hipotermia para o tratamento de asfixia neonatal
MXPA04001912A (es) Aminobenzofenonas novedosas.
PT1389122E (pt) Prevenção do cancro epitelial
MXPA05009849A (es) Terapia combinada que comprende nemorubicina y un inhibidor de la ciclooxigenasa-2.
HK1075390A1 (en) Citalopram for the treatment of elevated blood pressure
WO2006003222A9 (es) Uso del formoterol en el tratamiento profiláctico y/o terapéutico del desgaste muscular y/o síndrome caquéctico, asociados a estados catabólicos de ciertas enfermedades como cáncer, sida, infecciones, diabetes y otras
IL191690A0 (en) Therapy of malignant neoplasias
PL1700597T3 (pl) Kompozycja farmaceutyczna do podawania na skórę, zawierająca łącznie ubidekarenon, despantenol oraz chlorheksydynę lub jej farmakologicznie dopuszczalną sól
SI1817029T1 (sl) Derivati izoksazola za lajĺ anje nevropatskih boleäśin
TNSN06068A1 (en) Pharmaceutical composition containing in association ubidecarenone, dexpanthenol and chlorhexidine or a pharmaceutically acceptable salt thereof for cutaneous application